Citations

Clear

153 citation(s) found for "Gleich, GJ".

Transmigration of Eosinophils Through Basement Membrane Components In Vitro: Synergistic Effects of Platelet-Activating Factor and Eosinophil-Active Cytokines
Okada, Shinji , Kita, Hirohito , Gleich, G J, Leiferman, Kristin M. , George, Thomas J. , Kita, H

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 16 | Issue: 4 | Pages: 455-463

10.1165/ajrcmb.16.4.9115757 | PMID 9115757 Get It

Abstract Migration of eosinophils through the basement membrane barrier is an important step for their infiltration into tissues. To investigate the mechanism of transmigration, we used a chamber fitted with a Matrigel membrane as a model of the basement membrane. In this model, eosinophils treated with cytokines or chemotactic factors alone did not transmigrate from the upper to the lower chamber. However, platelet-activating factor (PAF) strongly induced transmigration of eosinophils stimulated by interleukin (IL)-5, indicating that both a cytokine and a chemotactic factor are required for eosinophil migration through Matrigel. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and IL-3 also stimulated eosinophil transmigration in the presence of PAF. Of seven eosinophil chemotactic factors tested, leukotriene B4, C5a, RANTES, macrophage inflammatory protein-1α, and IL-8 did not induce significant eosinophil transmigration. Only PAF and eotaxin induced transmigration of eosinophils through Matrigel in the presence of IL-5; PAF was more potent than eotaxin at the optimal concentration. In contrast, PAF, eotaxin, and RANTES all potently induced migration of eosinophils through bare membrane in the absence of IL-5. Finally, eosinophil migration through Matrigel was markedly reduced by a combination of anti-CD18 and anti-CD29 monoclonal antibodies, suggesting that it is mediated by β1- and β2-integrin adhesion molecules. Our findings demonstrate that eosinophil transmigration through a basement membrane model requires both a specific chemoattractant, such as PAF, and an eosinophil-activating cytokine, such as IL-5. This synergistic effect is likely important in the tissue accumulation of activated eosinophils in allergic and other eosinophil-associated diseases.
Migration of Eosinophils through Basement Membrane Components In Vitro : Role of Matrix Metalloproteinase-9
Okada, Shinji , Kita, Hirohito , George, Terry J., Gleich, Gerald J. , Leiferman, Kristin M. , Kita, H

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 17 | Issue: 4 | Pages: 519-528

10.1165/ajrcmb.17.4.2877 | PMID 9376127 Get It

Abstract In general, inflammatory cells cross basement membranes by producing proteinases. To investigate the role of proteinases in eosinophil basement membrane migration, we studied peripheral blood eosinophils in Matrigel®-coated chemotaxis chambers. Electron microscopy showed degradation of the Matrigel® layer when eosinophils, added to the upper chamber, transmigrated the membrane in the presence of both platelet-activating factor (PAF) in the lower chamber and interleukin (IL)-5 in both chambers. In the absence of either or both PAF and IL-5, no changes occurred in the Matrigel® layer. Matrigel® transmigration of eosinophils induced by PAF and IL-5 was inhibited by 1,10-phenanthroline, batimastat, 3,4-dichloroisocoumarin, chymostatin, and a neutralizing antibody for the matrix metalloproteinase (MMP)-9, indicating that serine proteinase(s) and MMP, specifically MMP-9, were involved in the transmigration of eosinophils through Matrigel®. In contrast, eosinophil migration through a bare membrane was not affected by batimastat. Using gelatin zymography and immunoblotting, MMP-9 was detected in the migration upper chamber supernatant of the eosinophil transmigration assay and in the conditioned medium of eosinophils. Release of MMP-9 by eosinophils was increased by IL-5, PAF, or both, but the substrate-degrading activity of MMP-9 was increased only in the presence of both IL-5 and PAF, indicating that the releasing and activating mechanisms of MMP-9 are involved in eosinophil basement membrane migration. This study implicates MMP-9 in basement membrane migration of eosinophils and suggests its involvement in inflammatory diseases where tissue eosinophilia plays a role.
Eosinophils Retain Their Granule Major Basic Protein in a Murine Model of Allergic Pulmonary Inflammation
Stelts, Dawn, Egan, Robert W., Falcone, Angela, Garlisi, Charles G., Gleich, Gerald J. , Kreutner, William, Kung, T T, Nahrebne, D.Kyle, Chapman, Richard W. , Minnicozzi, Michael

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 18 | Issue: 4 | Pages: 463-470

10.1165/ajrcmb.18.4.2957 | PMID 9533933 Get It

Abstract Accumulation of eosinophils in the lung with concomitant tissue damage are defining histopathologic features of human asthma. Through degranulation and the release of proinflammatory proteins such as major basic protein (MBP), eosinophils may perpetuate this inflammatory response. We investigated the extent of eosinophil degranulation in a murine model of allergic pulmonary inflammation. In this paradigm, the mice develop pulmonary eosinophilia, mucus hypersecretion, tissue damage, and airway edema and hyperreactivity. To evaluate the degree of eosinophil degranulation, we used a polyclonal antibody to murine MBP (mMBP) to perform dot blot analysis of bronchoalveolar lavage (BAL) cells and fluids, and immunohistochemical fluorescent analysis of lung tissue sections. After ovalbumin antigen challenge, we were unable to detect immunoreactive mMBP in the BAL fluids from either nonsensitized or sensitized mice. However, after lysis of the recoverable BAL cells, we were able to detect mMBP by immunoblot analysis, with the levels of immunoreactive mMBP directly related to the number of recoverable eosinophils. We also examined paraffin-embedded, lung tissue sections for patterns of mMBP deposition. Whereas lung sections from allergic mice revealed prominent peribronchial eosinophilia after antigen challenge, tissue sections from nonsensitized animals rarely displayed eosinophils. Despite the presence of numerous eosinophils, no immunohistologic evidence of extracellular mMBP could be found in antigen-challenged allergic mice. Furthermore, rechallenged allergic mice displayed a significant increase in the number of recruited pulmonary eosinophils but all immunoreactive mMBP was still intracellular. We conclude that the recruited pulmonary eosinophils have not substantially degranulated. These results suggest that, in this murine model of allergic inflammation, eosinophil degranulation and release of mMBP does not contribute to the observed pulmonary inflammation and airway hyperreactivity.
Stimulation of Neutrophil Interleukin-8 Production by Eosinophil Granule Major Basic Protein
Page, Scott M., Gleich, Gerald J. , Roebuck, Kenneth A., Thomas, Larry L.

Mayo Clinic

American Journal of Respiratory Cell and Molecular Biology | April 3, 2013 | Volume: 21 | Issue: 2 | Pages: 230-237

10.1165/ajrcmb.21.2.3647 | PMID 10423406 Get It

Abstract We evaluated the ability of eosinophil granule major basic protein (MBP) to stimulate interleukin (IL)-8 production by neutrophils. MBP over the concentration range of 0.1 to 10 μM stimulated the release of up to approximately 8 ng/ml IL-8. Incubation with 2 μM MBP showed that, after a 1 h lag, the level of IL-8 release increased with time for approximately 10 h. At the 2 μM concentration, eosinophil cationic protein, eosinophil-derived neurotoxin, and eosinophil peroxidase did not stimulate significant levels of IL-8 production. MBP stimulated 2-fold increases in IL-8 messenger RNA (mRNA) after 1 and 3 h of incubation, which were blocked by pretreatment with actinomycin D. However, stimulation with MBP did not produce an increase in the binding activity of nuclear factor (NF)-κB or activator protein-1. No NF–IL-6 binding activity was detected in the same nuclear extracts. In addition, stimulation with MBP prolonged the stability of IL-8 mRNA. MBP also induced transient increases in mRNA for macrophage inflammatory protein (MIP)-1α and MIP-1β, but did not stimulate the release of either chemokine. These findings indicate that MBP is selective among the eosinophil granule proteins as a stimulus for neutrophil IL-8 release and, further, that stimulation of neutrophil IL-8 release by MBP involves both transcriptional and posttranscriptional regulation. We postulate that MBP-induced release of IL-8 by neutrophils may contribute to the pathophysiology of acute asthma and other inflammatory lung diseases.
1,1' ‐Ethylidenebis‐ [tryptophan] induces pathologic alterations in muscle similar to those observed in the eosinophilia‐myalgia syndrome
Emslie‐Smith, Alison M., Mayeno, Arthur N., Gleich, G.J., Engel, Andrew G. , Nakano, Satoshi

Mayo Clinic

Neurology | May 13, 2012 | Volume: 44 | Issue: 12 | Pages: 2390-2390

10.1212/wnl.44.12.2390 | PMID 7991132 Get It

Sudden-Onset Fatal Asthma: A Distinct Entity with Few Eosinophils and Relatively More Neutrophils in the Airway Submucosa?
Sur, Sanjiv , Crotty, Thomas B., Kephart, Gail M., Hyma, Bruce A., Colby, Thomas V. , Reed, Charles E., Hunt, Loren W., Gleich, Gerald J.

Mayo Clinic

American Review of Respiratory Disease | August 3, 2011 | Volume: 148 | Issue: 3 | Pages: 713-719

10.1164/ajrccm/148.3.713 | PMID 8368644 Get It

Abstract To determine the histologic differences in the airways of patients who died from sudden-onset asthma and the more common slow-onset asthma, we studied seven cases of fatal asthma. The numbers of eosinophilsand neutrophils, as well as extracellular deposition of their respective granule contents in the airway mucosa and submucosa, were determined and statistically analyzed. Four of the seven patients had slow-onset asthma attacks in which the time interval between onset of asthma and death was more than 2.5 h. In contrast, three patients had sudden-onset asthma in which the time interval between onset of asthma attack and death was less than 1 h. The four patients with slow-onset fatal asthma had more eosinophils (34.1 ± 6.3 in slow-onset; 9.7 ± 3.5 in sudden-onset; p = 0.002) and fewer neutrophils (4.8 ± 2.0 in slow-onset; 16.8 ± 5.4 in sudden-onset; p = 0.008) in the airway submucosa than did patients with sudden-onset fatal asthma. In addition, within the slow-onset fatal asthma group, eosinophils exceeded neutrophils in the airway submucosa (eosinophils > neutrophils, p = 0.002). By contrast, within the sudden-onset fatal asthma group, neutrophils exceeded eosinophils (neutrophils > eosinophils, p = 0.04). We suggest that sudden-onset fatal asthma is immunohistologically distinct from slow-onset fatal asthma and that it is characterized by a relative paucity of eosinophils in the face of an excess of neutrophils in the airway submucosa. These observations raise the possibility that the mechanism of airway inflammation as well as that of airway narrowing in sudden-onset fatal asthma may be quite distinct from those in slow-onset fatal asthma.
Participation of eosinophils in the toxic oil syndrome
Ten, Rosa, Kephart, G M, POSADA, M, Abaitua, I., Soldevilla, Luis, Kilbourne, Edwin M., Dunnette, Sandra L., Gleich, Gerald J. , POSADA, M

Mayo Clinic

Clinical and Experimental Immunology | July 27, 2010 | Volume: 82 | Issue: 2 | Pages: 313-317

10.1111/j.1365-2249.1990.tb05445.x | PMID 2242612 Get It

SUMMARYThe participation of eosinophils in the Spanish toxic oil syndrome (TOS) was investigated. Eosinophil infiltration and degranulation in tissues from 52 patients with the TOS were examined by immunofluorescence staining for the eosinophil granule major basic protein (MBP). Serum MBP levels were determined in sera from 323 patients. Eosinophil infiltration and degranulation were found in several tissues, especially during the acute phase of the TOS, and serum MBP was significantly elevated during all phases of the disease, suggesting that eosinophils play a role in the pathogenesis of the TOS.
Eosinophil Ribonucleases and Their Cutaneous Lesion-Forming Activity
Plager, Douglas A., Davis, Mark D.P. , Andrews, Amy G., Coenen, Michael J., George, Terry J., Gleich, Gerald J. , Leiferman, Kristin M.

Mayo Clinic

The Journal of Immunology | August 28, 2009 | Volume: 183 | Issue: 6 | Pages: 4013-4020

10.4049/jimmunol.0900055 | PMID 19717523 Get It

Abstract Eosinophil granule proteins are deposited in cutaneous lesions in many human diseases, but how these proteins contribute to pathophysiology is obscure. We injected eosinophil cationic protein (ECP or RNase 3), eosinophil-derived neurotoxin (EDN or RNase 2), eosinophil peroxidase (EPO), and major basic protein-1 (MBP1) intradermally into guinea pig and rabbit skin. ECP and EDN each induced distinct skin lesions at ≥2.5 μM that began at 2 days, peaking at ∼7 days and persisting up to 6 wk. These lesions were ulcerated (ECP) or crusted (EDN) with marked cellular infiltration. EPO and MBP1 (10 μM) each produced perceptible induration and erythema with moderate cellular infiltration resolving within 2 wk. ECP and EDN localized to dermal cells within 2 days, whereas EPO and MBP1 remained extracellular. Overall, cellular localization and RNase activity of ECP and EDN were critical for lesion formation; differential glycosylation, net cationic charge, or RNase activity alone did not account for lesion formation. Ulcerated lesions from patients with the hypereosinophilic syndrome showed ECP and EDN deposition comparable to that in guinea pig skin. In conclusion, ECP and EDN disrupt skin integrity and cause inflammation. Their presence in ulcerative skin lesions may explain certain findings in human eosinophil-associated diseases.
Anesthesia for Cesarean Delivery and Learning Disabilities in a Population-based Birth Cohort
Flick, Randall P., Wilder, Robert T. , Katusic, Slavica K., Pike, Tasha L., Dingli, Mariella, Gleich, Stephen J. , Schroeder, Darrell R. , Barbaresi, William J. , Hanson, Andrew C. , Šprung, Juraj , Warner, David O. , Schroeder, Darrell

Mayo Clinic

Anesthesiology | July 16, 2009 | Volume: 111 | Issue: 2 | Pages: 302-310

10.1097/aln.0b013e3181adf481 | PMID 19602960 Get It

Background Anesthetics administered to immature brains may cause histopathological changes and long-term behavioral abnormalities. The association between perinatal exposure to anesthetics during Cesarean delivery (CD) and development of learning disabilities (LD) was determined in a population-based birth cohort. Methods The educational and medical records of all children born to mothers residing in five townships of Olmsted County, Minnesota from 1976-1982 and remaining in the community at age 5 were reviewed to identify those with LDs. Cox proportional hazards regression was used to compare rates of LD between children delivered vaginally and via CD (with general or regional anesthesia). Results Of the 5,320 children in this cohort, 497 were delivered via CD (under general anesthesia n = 193, and regional anesthesia n = 304). The incidence of LD depended on mode of delivery (P = 0.050, adjusted for sex, birth weight, gestational age, exposure to anesthesia before age 4 yr, and maternal education). LD risk was similar in children delivered by vagina or CD with general anesthesia, but was reduced in children receiving CD with regional anesthesia (hazard ratio = 0.64, 95% confidence interval 0.44 to 0.92; P = 0.017 for comparison of CD under regional anesthesia compared to vaginal delivery). Conclusion Children exposed to general or regional anesthesia during CD are not more likely to develop LD compared to children delivered vaginally, suggesting that brief perinatal exposure to anesthetic drugs does not adversely affect long-term neurodevelopmental outcomes. The risk of LD may be lower in children delivered by CD whose mothers received regional anesthesia.
Early Exposure to Anesthesia and Learning Disabilities in a Population-based Birth Cohort
Wilder, Robert T. , Flick, Randall P., Katusic, Slavica K., Barbaresi, William J. , Mickelson, Christopher, Gleich, Stephen J. , Schroeder, Darrell R. , Weaver, Amy L. , Šprung, Juraj , Warner, David O. , Schroeder, Darrell

Mayo Clinic

Anesthesiology | May 21, 2009 | Volume: 110 | Issue: 4 | Pages: 796-804

10.1097/01.anes.0000344728.34332.5d | PMID 19293700 Get It